Results point to a noticeable difference between the two main settings studied: Overall, results suggest that melatonin may have more value for ongoing musculoskeletal conditions than for short-term pain after an operation
Thermally reducing GO requires temperatures as high 1000 C or more which damages the structure of the graphene platelets
TB-500 makes more sense when: The injury is deep or hard to reach with an injection (spine, deep hip, cardiac tissue) You're dealing with multiple injuries at the same time Recovery involves systemic inflammation rather than something localized BPC-157 makes more sense when: The injury is easy to inject near (knee, shoulder, elbow, ankle) Gut healing is the main goal, since BPC-157's strongest documented effects are in the GI tract You're targeting a neurological issue through a localized administration route Neither peptide has human RCT data for musculoskeletal use yet
Though research conflicts on this point, glutathione appears to degrade in the gut when taken orally
Combining too many interventions simultaneously makes it impossible to identify what works
The effect of melatonin on glutathione and glutathione transferase and glutathione peroxidase activities in the mouse liver and kidney in vivo